Dulaglutide: Dosage, Protocol, and Research Guide
Long-acting GLP-1 receptor agonist with once-weekly dosing
Mechanism
GLP-1 receptor agonist fused with human IgG4 Fc fragment for extended half-life. Provides consistent GLP-1 receptor activation throughout the week, improving glycemic control and promoting weight loss.
Protocol at a glance
| Starting dose | 0.75mg |
|---|---|
| Maintenance dose | 1.5mg |
| Maximum dose | 4.5mg |
| Frequency | Once weekly |
| Typical duration | Ongoing therapy |
| Route | Subcutaneous |
| Injection site | Abdomen, thigh, or upper arm |
| Timing | Any time of day, with or without food |
Side effects
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Decreased appetite
Contraindications
- Type 1 diabetes
- History of pancreatitis
- MEN 2 syndrome
Protocol notes
- Pre-filled pen device for ease of use
- No dose mixing required
- Can be taken with or without food
- Store in refrigerator until first use
Frequently asked questions
How does Dulaglutide work in the body?
Dulaglutide activates GLP-1 receptors, which are found on pancreatic beta cells and throughout the central nervous system. When activated, these receptors trigger glucose-dependent insulin secretion in the pancreas, meaning insulin is released only when blood sugar is elevated. This reduces hypoglycemia risk. GLP-1 receptors in the brain regulate appetite, which is why Dulaglutide commonly causes appetite suppression and contributes to weight loss.
Is Dulaglutide legal?
The legal status of Dulaglutide depends on your jurisdiction and intended use. For research purposes only — not FDA-approved for human use. Consult a licensed physician before use. Any therapeutic use should be guided by a licensed healthcare provider.
What are the common side effects of Dulaglutide?
The most frequently reported side effects are gastrointestinal, including nausea, vomiting, diarrhea, abdominal pain, and decreased appetite. These effects typically diminish as the body adjusts to treatment over the first few weeks of use.
How often do you inject Dulaglutide?
Dulaglutide is administered once weekly via subcutaneous injection. You can inject it at any time of day, and food intake does not affect absorption, making it flexible to fit into any routine.
What is the starting dose for Dulaglutide?
The starting dose of Dulaglutide is 0.75mg once weekly. The maintenance dose is typically 1.5mg weekly, and the maximum recommended dose is 4.5mg weekly. Dosing should be adjusted under medical supervision.
Can you stack Dulaglutide with other compounds?
The interaction profile of Dulaglutide with other agents depends on the specific compounds being considered. Any combination therapy should be evaluated by a licensed healthcare provider before use to assess safety and efficacy.
How does Dulaglutide affect lab markers?
Research on Dulaglutide's effects on specific lab markers remains limited in the scope of commonly available data. Clinical trials such as AWARD-7 (PMID 29910024) have evaluated metabolic outcomes in specialized populations, but comprehensive lab marker profiles should be discussed with a healthcare provider.
How does Dulaglutide make you feel?
Individual responses vary, but many users report decreased appetite and increased satiety, which often leads to reduced caloric intake and weight loss. Gastrointestinal side effects—particularly nausea—may occur in the first 1-2 weeks of use but typically resolve as the body adapts. Some users report increased energy as appetite suppression reduces the metabolic demand of digestion.
More GLP-1 & Weight Loss peptides · All peptide guides · Free dose calculator
Educational reference only — not medical advice. Work with a qualified clinician.